AR040489A1 - Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen - Google Patents
Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienenInfo
- Publication number
- AR040489A1 AR040489A1 AR20030102502A ARP030102502A AR040489A1 AR 040489 A1 AR040489 A1 AR 040489A1 AR 20030102502 A AR20030102502 A AR 20030102502A AR P030102502 A ARP030102502 A AR P030102502A AR 040489 A1 AR040489 A1 AR 040489A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenyl
- compounds
- medicines
- alkyl
- hydrogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 4
- VYIBCOSBNVFEIW-UHFFFAOYSA-N 3-phenylpropanamide Chemical compound NC(=O)CCC1=CC=CC=C1 VYIBCOSBNVFEIW-UHFFFAOYSA-N 0.000 title 1
- APEJMQOBVMLION-UHFFFAOYSA-N cinnamic acid amide Natural products NC(=O)C=CC1=CC=CC=C1 APEJMQOBVMLION-UHFFFAOYSA-N 0.000 title 1
- WSDQIHATCCOMLH-UHFFFAOYSA-N phenyl n-(3,5-dichlorophenyl)carbamate Chemical compound ClC1=CC(Cl)=CC(NC(=O)OC=2C=CC=CC=2)=C1 WSDQIHATCCOMLH-UHFFFAOYSA-N 0.000 title 1
- APEJMQOBVMLION-VOTSOKGWSA-N trans-cinnamamide Chemical compound NC(=O)\C=C\C1=CC=CC=C1 APEJMQOBVMLION-VOTSOKGWSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 102000010909 Monoamine Oxidase Human genes 0.000 abstract 2
- 108010062431 Monoamine oxidase Proteins 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- -1 3-phenyl-propionamido, 3-phenyl-acrylamido Chemical group 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido de fórmula (1) en donde: R1 es alquilo (C1-3), halógeno, halógeno-alquilo(C1-6), ciano, alcoxilo (C1-6) o halógeno-alcoxilo(C1-6); R21, R22, R23 y R24 son cada uno independientemente seleccionados del grupo consistente en hidrógeno y flúor; R3 es hidrógeno o alquilo (C1-3); a es un grupo divalente de grupo de fórmulas (2), es hidrógeno o alquilo (C1-3); R5, R6 y R7 son cada uno independientemente hidrógeno o alquilo (C1-6); y n es, 2 ó 3. Su uso para la elaboración de medicamentos, un proceso para elaborar los compuestos de fórmula (1) y medicamentos que los contienen. Los compuestos de fórmula (1) así como sus sales farmacéuticamente aceptables son especialmente útiles para el tratamiento y prevención de enfermedades que están mediadas por inhibidores de monoamina oxidasa B (MAO-B), tales como la enfermedad de Alzheimer o la demencia senil.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02015583 | 2002-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040489A1 true AR040489A1 (es) | 2005-04-06 |
Family
ID=30011071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20030102502A AR040489A1 (es) | 2002-07-15 | 2003-07-11 | Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6900354B2 (es) |
| EP (1) | EP1523469B1 (es) |
| JP (1) | JP4108679B2 (es) |
| KR (1) | KR20050029206A (es) |
| CN (1) | CN1305838C (es) |
| AR (1) | AR040489A1 (es) |
| AT (1) | ATE410407T1 (es) |
| AU (1) | AU2003281030B2 (es) |
| BR (1) | BR0312658A (es) |
| CA (1) | CA2493372A1 (es) |
| DE (1) | DE60323981D1 (es) |
| ES (1) | ES2314219T3 (es) |
| MX (1) | MXPA05000583A (es) |
| PA (1) | PA8577201A1 (es) |
| PE (1) | PE20040667A1 (es) |
| PL (1) | PL373390A1 (es) |
| RU (1) | RU2318802C2 (es) |
| TW (1) | TW200404760A (es) |
| UY (1) | UY27894A1 (es) |
| WO (1) | WO2004007429A1 (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1588704A1 (en) * | 2004-04-22 | 2005-10-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
| KR100966749B1 (ko) | 2004-05-26 | 2010-06-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 화합물 |
| KR20070083781A (ko) * | 2004-10-26 | 2007-08-24 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 화합물의 비정질체 |
| EP1855655A2 (en) | 2005-02-25 | 2007-11-21 | F. Hoffmann-Roche AG | Tablets with improved drug substance dispersibility |
| ATE540675T1 (de) * | 2005-04-01 | 2012-01-15 | Wellstat Therapeutics Corp | Verbindungen zur behandlung von stoffwechselstörungen |
| US8138209B2 (en) * | 2005-07-13 | 2012-03-20 | Jenrin Discovery, Inc. | Substituted picolinamides as MAO-B inhibitors useful for treating obesity |
| PL209602B1 (pl) | 2005-10-20 | 2011-09-30 | Inst Chemii Bioorg Pan | Sposób otrzymywania amidu kwasu 3-(4-hydroksyfenylo)propanowego |
| US20090270623A1 (en) * | 2005-11-18 | 2009-10-29 | Naoyuki Shimomura | Process for production of cinnamide derivative |
| EP1953151A4 (en) * | 2005-11-18 | 2010-06-02 | Eisai R&D Man Co Ltd | SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF |
| AU2006317457B2 (en) * | 2005-11-24 | 2011-09-08 | Eisai R & D Management Co., Ltd. | Morpholine type cinnamide compound |
| TWI370130B (en) * | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| CN101312965B (zh) * | 2005-11-24 | 2011-07-20 | 卫材R&D管理有限公司 | 吗啉型肉桂酰胺化合物 |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| SA07280403B1 (ar) * | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | ملح رباعي لمركب سيناميد |
| TW200848054A (en) * | 2007-02-28 | 2008-12-16 | Eisai R&D Man Co Ltd | Two cyclic oxomorpholine derivatives |
| CA2687262A1 (en) * | 2007-05-16 | 2008-11-20 | Naoyuki Shimomura | One-pot production process for cinnamide derivative |
| US7986144B2 (en) * | 2007-07-26 | 2011-07-26 | Schlumberger Technology Corporation | Sensor and insulation layer structure for well logging instruments |
| US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| CA2694401C (en) | 2007-08-31 | 2012-12-04 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
| AU2009210070A1 (en) * | 2008-01-28 | 2009-08-06 | Eisai R & D Management Co., Ltd. | Crystalline cinnamide compounds or salts thereof |
| NL2005655A (en) | 2009-12-09 | 2011-06-14 | Asml Netherlands Bv | A lithographic apparatus and a device manufacturing method. |
| CN104030941B (zh) * | 2014-06-23 | 2016-04-27 | 常州大学 | 一种3-（4-羟基苯基）丙酰胺的合成方法 |
| CN107011313B (zh) | 2016-01-27 | 2021-11-30 | 天士力医药集团股份有限公司 | 取代桂皮酰胺衍生物在制备抗焦虑药物中的应用 |
| US11173136B2 (en) | 2018-01-10 | 2021-11-16 | Brightseed, Inc. | Method for modulating metabolism |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2645019A1 (es) | 1989-03-30 | 1990-10-05 | Fournier Innovation Synergie | |
| US5679715A (en) | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
| CA2244253C (en) | 1996-03-15 | 2002-11-12 | Somerset Pharmaceuticals, Inc. | Method for preventing and treating peripheral neuropathy by administering selegiline |
| AU1359801A (en) | 1999-11-05 | 2001-06-06 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
-
2003
- 2003-07-03 US US10/613,785 patent/US6900354B2/en not_active Expired - Fee Related
- 2003-07-07 BR BR0312658-7A patent/BR0312658A/pt not_active IP Right Cessation
- 2003-07-07 ES ES03740425T patent/ES2314219T3/es not_active Expired - Lifetime
- 2003-07-07 EP EP03740425A patent/EP1523469B1/en not_active Expired - Lifetime
- 2003-07-07 KR KR1020057000637A patent/KR20050029206A/ko not_active Ceased
- 2003-07-07 DE DE60323981T patent/DE60323981D1/de not_active Expired - Fee Related
- 2003-07-07 AT AT03740425T patent/ATE410407T1/de not_active IP Right Cessation
- 2003-07-07 CA CA002493372A patent/CA2493372A1/en not_active Abandoned
- 2003-07-07 RU RU2005104104/04A patent/RU2318802C2/ru not_active IP Right Cessation
- 2003-07-07 CN CNB038160579A patent/CN1305838C/zh not_active Expired - Fee Related
- 2003-07-07 JP JP2004520497A patent/JP4108679B2/ja not_active Expired - Fee Related
- 2003-07-07 AU AU2003281030A patent/AU2003281030B2/en not_active Ceased
- 2003-07-07 PL PL03373390A patent/PL373390A1/xx unknown
- 2003-07-07 WO PCT/EP2003/007231 patent/WO2004007429A1/en not_active Ceased
- 2003-07-07 MX MXPA05000583A patent/MXPA05000583A/es active IP Right Grant
- 2003-07-10 PA PA20038577201A patent/PA8577201A1/es unknown
- 2003-07-11 AR AR20030102502A patent/AR040489A1/es not_active Application Discontinuation
- 2003-07-14 UY UY27894A patent/UY27894A1/es not_active Application Discontinuation
- 2003-07-15 PE PE2003000706A patent/PE20040667A1/es not_active Application Discontinuation
- 2003-07-15 TW TW092119275A patent/TW200404760A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050029206A (ko) | 2005-03-24 |
| EP1523469B1 (en) | 2008-10-08 |
| CA2493372A1 (en) | 2004-01-22 |
| UY27894A1 (es) | 2003-12-31 |
| US6900354B2 (en) | 2005-05-31 |
| RU2318802C2 (ru) | 2008-03-10 |
| US20040034096A1 (en) | 2004-02-19 |
| AU2003281030A1 (en) | 2004-02-02 |
| PL373390A1 (en) | 2005-08-22 |
| AU2003281030B2 (en) | 2009-05-28 |
| ATE410407T1 (de) | 2008-10-15 |
| CN1305838C (zh) | 2007-03-21 |
| PE20040667A1 (es) | 2004-09-25 |
| DE60323981D1 (de) | 2008-11-20 |
| PA8577201A1 (es) | 2004-02-07 |
| RU2005104104A (ru) | 2005-10-10 |
| BR0312658A (pt) | 2005-04-26 |
| WO2004007429A1 (en) | 2004-01-22 |
| CN1665774A (zh) | 2005-09-07 |
| EP1523469A1 (en) | 2005-04-20 |
| ES2314219T3 (es) | 2009-03-16 |
| TW200404760A (en) | 2004-04-01 |
| MXPA05000583A (es) | 2005-04-19 |
| JP4108679B2 (ja) | 2008-06-25 |
| JP2005533092A (ja) | 2005-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR040489A1 (es) | Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen | |
| AR041297A1 (es) | Derivados de 4-pirrolidino- fenil- bencil eter | |
| SE0104334D0 (sv) | Therapeutic agents | |
| PE20040155A1 (es) | Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen | |
| UY28339A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
| DE602005016261D1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
| HUP0400992A2 (hu) | Karbonsavval helyettesített oxazol-származékok, eljárás előállításukra és PPAR-alfa- és -gamma-aktivátorként való alkalmazásuk diabétesz kezelésére felhasználható gyógyszerek készítésére | |
| BR122012009489B8 (pt) | processo para produzir 2-etóxi-1-{[2-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso | |
| AR029717A1 (es) | Derivados del pro-farmaco de 4-fenil-piridina | |
| NO20062135L (no) | Fenylderivater som PPAR-agonister | |
| NO20061406L (no) | Organiske forbindelser | |
| NO20090327L (no) | Nye forbindelser 384 | |
| AR040253A1 (es) | Fluorobenzamidas, procesos de preparacion y medicamento | |
| AR040133A1 (es) | Derivados de n-acilamino bencil eter | |
| EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
| AR039651A1 (es) | Derivados de isoquinolina | |
| AR042362A1 (es) | Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen | |
| ECSP088257A (es) | Derivados de amida | |
| AR038342A1 (es) | Derivados piridin-amido | |
| CO5590934A2 (es) | Procedimiento de preparacion de derivados de equinocandina | |
| NO20070972L (no) | Benzyloksyderivater som MAOB-inhibitorer | |
| ATE399164T1 (de) | Antagonisten des opioidrezeptors | |
| AR066086A1 (es) | Derivados de dihidro-benzo (b)(1,4)diazepin-2-ona-sulfonamida | |
| EA200700179A1 (ru) | Производные пиррола, их получение и их применение в терапии | |
| DE602005015223D1 (de) | 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-on-derivate und verwandte verbindungen zur behandlung von erkrankungen des zentralnervensystems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |